CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- 4 Open-market buy Director bought 38,710 shares at $5.26 ($203,615)
- 4 Open-market buy Director bought 2,839 shares at an average $4.99 ($14,171)
- 4 Open-market buy Director bought 4,404,162 shares at an average $3.29 ($14,500,672)
- 4 Open-market buy 10% owner bought 20,829 shares at $3.25 ($67,694)
- 4 Open-market buy Director bought 42,726 shares at $3.25 ($138,860)
- 4 Open-market buy Director bought 6,943 shares at $3.25 ($22,565)
- 4 Open-market buy Director bought 833,153 shares at $3.25 ($2,707,747)
- 4 Open-market buy Director bought 833,153 shares at $3.25 ($2,707,747)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 18,564 shares (grant or award)
- 4 Grant or award Director acquired 18,564 shares (grant or award)
- 4 Grant or award Director acquired 18,564 shares (grant or award)
- 4 Grant or award VP and General Counsel acquired 26,918 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 34,035 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 32,488 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 27,847 shares (grant or award)
- 4 Grant or award President and CEO acquired 88,181 shares (grant or award)
Page 12 of 17 · 321 filings